Latest Issue of Science News

cover of the October 4 Science News


Parasite payback

Leishmania might be vulnerable to a common anticancer drug

The breast cancer drug tamoxifen kills the single-celled parasite known as leishmania, a scourge common in the tropics, Brazilian scientists report. While the tests in mice are preliminary, the finding is heartening because few good treatments for leishmaniasis exist, says Silvia Uliana, a physician at the University of São Paulo.

Note: To comment, Science News subscribing members must now establish a separate login relationship with Disqus. Click the Disqus icon below, enter your e-mail and click “forgot password” to reset your password. You may also log into Disqus using Facebook, Twitter or Google.

This article is available only to subscribing members. Join SSP today or Log in.